Transcranial Magnetic Stimulation (TMS) for PTSD: Insights from a Multisite Real-World Cohort
Posttraumatic stress disorder (PTSD) remains a complex and often persistent condition, particularly among military Veterans, where symptom burden may continue despite psychotherapy and pharmacological interventions. In this context, transcranial magnetic stimulation (TMS), a non-invasive neuromodulation technique, is increasingly being explored in clinical research, although it is not currently approved for the treatment of PTSD.
A large multisite retrospective cohort study from the VA Clinical TMS Program provides real-world data on the use of TMS in patients with PTSD and comorbid major depressive disorder. The study included more than 750 Veterans across over 30 clinical sites, with 658 patients receiving one of three FDA-cleared TMS protocols for depression.
In this cohort, transcranial magnetic stimulation (TMS) was associated with clinically meaningful reductions in PTSD symptom severity across all evaluated stimulation protocols, including 10 Hz repetitive TMS (rTMS), intermittent theta burst stimulation (iTBS), and “deep” TMS (dTMS).
Response rates ranged from 63 to 78 percent, while remission rates ranged from 47 to 49 percent, with no statistically significant differences observed between protocols.
Depressive symptoms also improved across treatment groups, consistent with the presence of comorbid major depressive disorder. A modest association between longer treatment duration and greater symptom improvement was observed, while differences between stimulation approaches remained limited.
These findings provide real-world evidence on how TMS is being applied in patients with PTSD within a large healthcare system. The results indicate that multiple stimulation protocols may be associated with similar clinical outcomes in this population.
As a retrospective cohort analysis, the study describes associations observed in routine clinical practice and does not establish causality or comparative efficacy between protocols. Further prospective and controlled studies are needed to better define the role of TMS in PTSD and to clarify optimal treatment parameters.
Access the full peer-reviewed study:
TMS for posttraumatic stress disorder: A multisite, propensity-matched cohort study
